Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?

European Urology

Volumn 51, Issue 4, 2007, Pages 931-939

  Vis, André N ^a   Roemeling, Stijn ^a   Kranse, Ries ^b   Schröder, Fritz H ^a   van der Kwast, Theo H ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Biopsy; Gleason score; Grading; Prognosis; Prostate cancer; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RELAPSE;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 33847148917     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.07.051     Document Type: Article

References (32)

1. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep 50 (1966) 125-128
2. Gleason D.F. Histologic grading of prostate cancer: a perspective. Hum Pathol 23 (1992) 273-279
3. Mostofi F.K. Grading of prostatic adenocarcinoma. Cancer Chemother Rep 59 (1975) 111-117
4. Brawn P.N., Ayala A.G., Von Eschenbach A.C., et al. Histological grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods-a preliminary study. Cancer 49 (1982) 525-532
5. Gleason D.F., Mellinger G.T., and the Veterans Administration Cooperative Urologic Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
6. Epstein J.I., Allsbrook W.C., Amin M.B., et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228-1242
7. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 281 (1999) 1395-1400
8. Cheng L., Koch M.O., Juliar B.E., et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 23 (2005) 2911-2917
9. Van der Kwast Th.H., Lopes C., Santonja C., et al. Guidelines for processing and reporting prostatic needle biopsies. J Clin Pathol 56 (2003) 336-340
10. Montironi R., van der Kwast T., Boccon-Gibod L., et al. Handling and pathology reporting of radical prostatectomy specimens. Eur Urol 44 (2003) 626-636
11. Descazeaud A., Rubin M.A., Allory Y., et al. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer. Eur Urol 48 (2005) 911-915
12. Roobol M.J., Kirkels W.J., and Schröder F.H. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, The Netherlands). BJU Int 92 (2003) 48-54
13. Rietbergen J.B.W., Boeken Kruger A.E., Kranse R., et al. Complications of transrectal ultrasound (TRUS) guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population based screening program. Urology 49 (1997) 875-880
14. Stamey T.A., McNeal J.E., Freiha F.S., et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139 (1988) 1235-1241
15. Hoedemaeker R.F., Ruijter E.T.G., Ruizeveld-de Winter J.A., et al., the Biomed II MPC study group. Processing radical prostatectomy specimens. J Urol Pathol 9 (1998) 211-222
16. Hoedemaeker R.F., Rietbergen J.B.W., Kranse R., et al. Comparison of pathological characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. World J Urol 15 (1997) 339-345
17. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
18. Draisma G., Boer R., Otto S.J., et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95 (2003) 868-878
19. Van der Kwast Th.H., Roobol M.J., Wildhagen M.F., et al. Consistency of prostate cancer grading results in screened populations across Europe. BJU Int 92 (2003) 88-91
20. Hoedemaeker R.F., Van der Kwast Th.H., Boer R., et al. Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst 93 (2001) 1153-1158
21. Stamey T.A. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA. BJU Int 94 (2004) 963-964
22. Sakr W.A., Tefilli M.V., Grignon D.J., et al. Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology 56 (2000) 730-734
23. Han M., Snow P.B., Epstein J.I., et al. A neural network predicts progression for men with Gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology 56 (2000) 994-999
24. Herman C.M., Kattan M.W., Ohori M., et al. Primary Gleason pattern as a predictor of disease progression in Gleason score 7 prostate cancer. Am J Surg Pathol 25 (2001) 657-660
25. Lau W.K., Blute M.L., Bostwick D.G., et al. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol 166 (2001) 1692-1697
26. Green G.A., Hanlon A.L., Al-Saleem T., et al. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer 83 (1998) 971-976
27. Tefilli M.V., Gheiler E.L., Tiguert R., et al. Should Gleason score 7 prostate cancer be considered a unique grade category. Urology 53 (1999) 372-377
28. Pan C.C., Potter S.R., Partin A.W., et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens. Am J Surg Pathol 24 (2000) 563-569
29. Graefen M., Noldus J., Pichlmeier U., et al. Early prostate-specific antigen relapse after retropubic radical prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol 36 (1999) 21-30
30. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
31. Johansson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713-2719
32. Kattan M.W., Eastham J.A., Stapleton A.M.F., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771